O

Osanni Bio

Development-stage therapeutics platform advancing drug programs

Vice President of Clinical Operations

Clinical Research OperationsUpdated on Nov 11
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree in life sciences, nursing, or a related field is required.
  • At least 15 years of clinical operations experience in biotech or pharma, including at least 5 years in a senior leadership role managing clinical operations teams.
  • A proven track record leading global Phase 2 and Phase 3 trials from startup through close-out.
  • Deep expertise in CRO and vendor selection, contracting, and oversight, including outsourced and hybrid operating models.
  • Thorough working knowledge of ICH GCP, FDA, EMA, and other global regulatory requirements, with hands-on experience preparing for and supporting health authority inspections.
  • Strong financial acumen, with experience building and managing multi-million-dollar clinical trial budgets and forecasts.
  • Experience building clinical operations functions, teams, and processes in a venture-backed or early-stage biotech environment.
  • Willingness to travel domestically and internationally as needed, approximately 20–25%.

Responsibilities

  • Lead the Clinical Operations function and own end-to-end execution of clinical trials from study startup through database lock and close-out.
  • Build and scale the Clinical Operations organization, including hiring, developing, and mentoring clinical trial managers and clinical operations professionals as the pipeline advances.
  • Develop and execute global clinical operations strategy for programs, including Phase 2 and pivotal studies across US and ex-US geographies.
  • Partner with the Chief Medical Officer and Clinical Development on protocol design, feasibility, and study planning, ensuring trial designs are operationally achievable and aligned with program objectives.
  • Own CRO and vendor strategy, including selection, contracting, oversight, and performance management of CROs, central reading centers, imaging vendors, labs, IRT, and other clinical service providers.
  • Drive site selection, activation, and enrollment strategy, building relationships with KOLs, key investigators, and leading clinical sites.
  • Collaborate with Regulatory Affairs on IND, CTA, and health authority submissions, ensuring clinical documentation and operational plans support regulatory strategy and inspection readiness.
  • Partner with CMC and Supply Chain to plan and manage clinical drug supply, packaging, labeling, and distribution to sites.
  • Work with Quality to ensure studies comply with ICH GCP, FDA, EMA, and local regulations; maintain audit and inspection readiness and oversee the Trial Master File.
  • Collaborate with Biostatistics and Data Management to ensure timely, high-quality data collection, cleaning, and database lock.
  • Own clinical trial budgets, forecasts, and timelines with Finance, and report study progress, risks, and mitigations to the CMO, executive leadership, and Board.
  • Establish scalable clinical operations processes, SOPs, systems, and metrics to support growth from early clinical to late-stage development.
  • Manage multiple priorities and complete deliverables accurately and on time in a fast-paced, evolving environment.

Desired Qualifications

  • An advanced degree such as an MS, MPH, PhD, PharmD, RN, MD, or MBA.
  • Experience supporting an NDA, BLA, or MAA submission.
  • Ophthalmology or retina clinical trial experience, including familiarity with intravitreal therapies, ocular imaging endpoints, and central reading centers.

About the Company

Osanni Bio

Development-stage therapeutics platform advancing drug programs

Osanni Bio uses a centralized innovation engine paired with a network of affiliate companies to discover, de-risk, and advance drug programs to proof-of-concept, then spins out successful programs as independent companies to scale. It generates drug concepts and progresses them to PoC through its central research engine and affiliate network. Unlike traditional pharma pipelines, it combines central science with a spin-out model to pursue capital-efficient, rapid PoC development. Its goal is to accelerate medicines in ophthalmology and cardiology with efficient progression to PoC and scalable programs.

Company size
11-50
Company stage
Series B
Total funding
$217M
Headquarters
San Francisco, CA
Founded
2023

Recently Posted Jobs

Explore more opportunities at Osanni Bio

See more jobs